Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease
- PMID: 26693732
- DOI: 10.2174/1568026616666151223113540
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease
Abstract
Breathomics, the multidimensional molecular analysis of exhaled breath, includes analysis of exhaled breath with gas-chromatography/mass spectrometry (GC/MS) and electronic noses (e-noses), and metabolomics of exhaled breath condensate (EBC), a non-invasive technique which provides information on the composition of airway lining fluid, generally by high-resolution nuclear magnetic resonance (NMR) spectroscopy or MS methods. Metabolomics is the identification and quantification of small molecular weight metabolites in a biofluid. Specific profiles of volatile compounds in exhaled breath and metabolites in EBC (breathprints) are potentially useful surrogate markers of inflammatory respiratory diseases. Electronic noses (e-noses) are artificial sensor systems, usually consisting of chemical cross-reactive sensor arrays for characterization of patterns of breath volatile compounds, and algorithms for breathprints classification. E-noses are handheld, portable, and provide real-time data. E-nose breathprints can reflect respiratory inflammation. E-noses and NMR-based metabolomics of EBC can distinguish patients with respiratory diseases such as asthma, COPD, and lung cancer, or diseases with a clinically relevant respiratory component including cystic fibrosis and primary ciliary dyskinesia, and healthy individuals. Breathomics has also been reported to identify patients affected by different types of respiratory diseases. Patterns of breath volatile compounds detected by e-nose and EBC metabolic profiles have been associated with asthma phenotypes. In combination with other -omics platforms, breathomics might provide a molecular approach to respiratory disease phenotyping and a molecular basis to tailored pharmacotherapeutic strategies. Breathomics might also contribute to identify new surrogate markers of respiratory inflammation, thus, facilitating drug discovery. Validation in newly recruited, prospective independent cohorts is essential for development of e-nose and EBC NMRbased metabolomics techniques.
Similar articles
-
The electronic nose in respiratory medicine.Respiration. 2013;85(1):72-84. doi: 10.1159/000340044. Epub 2012 Sep 25. Respiration. 2013. PMID: 23018197 Review.
-
Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases.Curr Pharm Des. 2017;23(14):2050-2059. doi: 10.2174/1381612823666170130155627. Curr Pharm Des. 2017. PMID: 28137216 Review.
-
Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.Anal Chim Acta. 2013 Dec 17;805:1-18. doi: 10.1016/j.aca.2013.07.049. Epub 2013 Jul 31. Anal Chim Acta. 2013. PMID: 24296139 Review.
-
Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases.Adv Clin Chem. 2019;88:121-149. doi: 10.1016/bs.acc.2018.10.002. Epub 2018 Nov 22. Adv Clin Chem. 2019. PMID: 30612604 Review.
-
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy.Eur Respir J. 2008 Nov;32(5):1175-83. doi: 10.1183/09031936.00072408. Epub 2008 Jul 24. Eur Respir J. 2008. PMID: 18653649
Cited by
-
Factors Influencing Continuous Breath Signal in Intubated and Mechanically-Ventilated Intensive Care Unit Patients Measured by an Electronic Nose.Sensors (Basel). 2016 Aug 22;16(8):1337. doi: 10.3390/s16081337. Sensors (Basel). 2016. PMID: 27556467 Free PMC article.
-
A Clinical Breathomics Dataset.Sci Data. 2024 Feb 14;11(1):203. doi: 10.1038/s41597-024-03052-2. Sci Data. 2024. PMID: 38355591 Free PMC article.
-
Noninvasive Recognition and Biomarkers of Early Allergic Asthma in Cats Using Multivariate Statistical Analysis of NMR Spectra of Exhaled Breath Condensate.PLoS One. 2016 Oct 20;11(10):e0164394. doi: 10.1371/journal.pone.0164394. eCollection 2016. PLoS One. 2016. PMID: 27764146 Free PMC article.
-
Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.Respir Med. 2016 Dec;121:59-66. doi: 10.1016/j.rmed.2016.10.011. Epub 2016 Oct 21. Respir Med. 2016. PMID: 27888993 Free PMC article.
-
Analyses of short-chain fatty acids and exhaled breath volatiles in dietary intervention trials for metabolic diseases.Exp Biol Med (Maywood). 2021 Apr;246(7):778-789. doi: 10.1177/1535370220979952. Epub 2020 Dec 16. Exp Biol Med (Maywood). 2021. PMID: 33327781 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous